What matters
(EVMN) Skip to main content Skip to section navigation Skip to footer chevron_left Back to Evommune.com Check Out the EADV Webinar of Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria.
(EVMN) Skip to main content Skip to section navigation Skip to footer chevron_left Back to Evommune.com Check Out the EADV Webinar of Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria.
(EVMN) Skip to main content Skip to section navigation Skip to footer chevron_left Back to Evommune.com Check Out the EADV Webinar of Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria.
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open Investor relationsGet material earnings, filing, IR, and earnings-call alerts by email.